ARD-0403

DRUG3 trials

Sponsors

Ardana Bioscience Ltd

Conditions

Hypogonadism

Phase 2

Study of 3 Doses of ARD-0403 in Testosterone Deficient Men

CompletedNCT00597051

Ardana Bioscience LtdHypogonadism

Start: 2005-10-31End: 2006-02-28Updated: 2008-01-17

Phase 3

Open-Label Study of ARD-0403 in Testosterone Deficient Men

CompletedNCT00448955

Ardana Bioscience LtdHypogonadism

Start: 2007-05-31End: 2008-02-29Target: 150Updated: 2008-04-18

Open-Label Study of ARD-0403 in Testosterone Deficient Men

TerminatedNCT00562731

Ardana Bioscience LtdHypogonadism

Start: 2007-10-31End: 2008-06-30Target: 150Updated: 2008-04-01